Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

3 terminated/withdrawn out of 6 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05160636Active Not Recruiting

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza

Role: collaborator

NCT06703190Terminated

Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine

Role: collaborator

NCT05357404Active Not Recruiting

Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE

Role: collaborator

NCT02202421Not ApplicableTerminated

T-ABA Group Based Early Intervention For Parents of Children With ASD

Role: collaborator

NCT02015806Not ApplicableCompleted

Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices

Role: collaborator

NCT01963156Not ApplicableTerminated

Synchronization to Improve Non-Adherence to Cardiovascular Medications

Role: collaborator

All 6 trials loaded